Erasca to present updated ERAS-0015 clinical data at EORTC-NCI-AACR symposium
Erasca said it will deliver an oral presentation on updated ERAS-0015 monotherapy clinical data, covering additional patients and longer follow-up from AURORAS-1 Phase 1. It also plans a poster on nonclinical combination data for ERAS-0015.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.